519 672 2121
Close mobile menu
Showing 201 - 210 of 532

Valeant Pharmaceuticals

Siskinds LLP (“Siskinds”) is co-counsel in proposed securities class actions against Valeant Pharmaceuticals International, Inc. (“Valeant”), certain of its directors and officers, and its auditor PricewaterhouseCoopers LLP (“PwC”). These class actions arise from the circumstances surrounding Valeant’s previously undisclosed relationships with Philidor Rx Services, LLC and other specialty pharmacies in the conduct of its business...

Continue reading the post titled Valeant Pharmaceuticals

Manulife Financial Corporation

Please be advised that the claims process is now complete and all payments have been distributed. This action, which was commenced in July 2009, alleges that Manulife Financial Corporation (“Manulife”) and certain of its current and former officers and directors negligently made misrepresentations relating to Manulife’s risk management practices and policies during the period between...

Continue reading the post titled Manulife Financial Corporation

IKO Roofing Shingles

What is this class action about? The representative plaintiff, on behalf of himself and the Class, claimed damages from the defendants (IKO Industries Ltd., Canroof Corporation Inc., and I.G. Machine & Fibers Ltd.) for the alleged negligent design and manufacture of IKO Organic Shingles. A settlement has been reached in the litigation. The settlement was...

Continue reading the post titled IKO Roofing Shingles

Actos

Actos (pioglitazone hydrochloride) is an oral anti-diabetic drug manufactured by Takeda and prescribed to decrease blood sugar levels in patients with type 2 diabetes. A Canada-wide settlement has been reached in five proposed class actions relating to the prescription drugs ACTOS®, APO-Pioglitazone and SANDOZ-Pioglitazone. Hearings were held in the supervising Courts in Québec and Ontario...

Continue reading the post titled Actos

Avandia

A Canada-wide settlement was reached and approved on June 13, 2019 by the Supreme Court of Nova Scotia. The Claims Deadline for filing a claim under the settlement was on July 15, 2020. The settlement has now concluded and no further claims are being accepted. Avandia, a drug used to treat diabetes, is associated with...

Continue reading the post titled Avandia